Efficacy shortfall in DUPLEX-AD study Johnson & Johnson (J&J) has decided to halt the Phase 2 clinical trial of its... Read more
Category: Uncategorized
Senhwa Biosciences enters global ADC market with novel combination therapy
Synergy between G4 Stabilizer and leading ADC technology Senhwa Biosciences has reached a clinical milestone by initiating a Phase 1b... Read more
EirGenix licenses Transcenta’s HiCB platform to revolutionize bioprocessing
Strategic partnership for advanced biomanufacturing Transcenta Therapeutics and EirGenix Inc. have entered into a strategic non-exclusive licensing agreement, granting EirGenix... Read more
Akari Therapeutics initiates GMP manufacturing for breakthrough ADC AKTX-101
A pivotal step toward Phase 1 clinical trials Akari Therapeutics has officially launched GMP (Good Manufacturing Practice) activities for its... Read more
American Academy of Pediatrics sues U.S. government over $12 million funding cut
Legal battle over federal grants for child health The American Academy of Pediatrics (AAP) has filed a lawsuit against the... Read more
Sanofi expands vaccine portfolio with $2.2 billion acquisition of Dynavax
Strengthening adult immunization strategic assets The French pharmaceutical giant Sanofi has reached a definitive agreement to acquire Dynavax Technologies for... Read more
Proposed food law mandates transparency in social media advertising
Stricter oversight for specialized nutritional products Health authorities are finalizing amendments to the Food Safety Law, focusing on heightened technical... Read more
Completion of international-standard pre-hospital emergency care pilot phase
Deploying "mobile emergency rooms" across six provinces The national pre-hospital emergency system development project, supported by a 1,000 billion VND... Read more
Strategic directions for breakthrough in public healthcare (2026 – 2030)
Recognizing strategic achievements in the health sector At the recent national conference reviewing the 2021-2025 term, Government leaders commended the... Read more









